Dr. Henry “Mark” Dunnenberger is Director of Pharmacogenomics, at NorthShore University HealthSystem. Mark received his BS in philosophy/biology from the University of North Carolina and PharmD degree from the University of Tennessee. He completed a PGY1 Pharmacy Practice residency at Mission Hospital in Asheville, NC and a PGY2 residency in Clinical Pharmacogenetics at St. Jude Children’s Research Hospital in Memphis, TN. Mark is a Board Certified Pharmacotherapy Specialist (BCPS). Mark has been an active member of the Clinical Pharmacogenomics Implementation Consortium (CPIC) for 6 years and has co-authored several guidelines. He has been a member of CPIC’s informatics working group since its inception. His teaching, research, and patient care activities focus on clinical implementation of pharmacogenomics including the use of novelty care delivery mechanisms and clinical decision support tools. Recent areas of innovation include developing a dedicated multidisciplinary pharmacogenomics clinic. He has been an author on 9 peer-reviewed papers, including a manuscript entitled "Developing Knowledge Resources to Support Precision Medicine: Principles from the Clinical Pharmacogenetics Implementation Consortium (CPIC)" published in JAMIA March of 2016.